Cerena Chen
Stock Analyst at Wells Fargo
(2.79)
# 1,693
Out of 5,246 analysts
5
Total ratings
75%
Success rate
37.21%
Average return
Main Sectors:
Stocks Rated by Cerena Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MSTR Strategy | Downgrades: Equal-Weight | $65 → $54 | $159.89 | -66.23% | 1 | Sep 30, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Overweight | $40 → $35 | $18.41 | +90.11% | 1 | May 8, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Overweight | $160 → $165 | $235.97 | -30.08% | 3 | May 6, 2025 |
Strategy
Sep 30, 2025
Downgrades: Equal-Weight
Price Target: $65 → $54
Current: $159.89
Upside: -66.23%
Amphastar Pharmaceuticals
May 8, 2025
Maintains: Overweight
Price Target: $40 → $35
Current: $18.41
Upside: +90.11%
Axsome Therapeutics
May 6, 2025
Maintains: Overweight
Price Target: $160 → $165
Current: $235.97
Upside: -30.08%